INmune Bio, Inc.

NASDAQ:INMB

5.72 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015
Operating Activities:
Net Income -30.008-27.299-30.34-12.099-7.678-12.44-0.831-0.277-0.049
Depreciation & Amortization 0.22400000000
Deferred Income Tax 000000000
Stock Based Compensation 7.3687.1494.7963.1124.09710.0010.200.12
Change In Working Capital 10.436-2.864-3.0860.044-0.2610.380.02-0.090.001
Accounts Receivables 6.019-2.957-3.705-1.1530.002-0.32-0.067-0.260
Inventory 02.9573.7051.153-0.0020000
Accounts Payables 2.7211.4022.2611.075-0.1320.5140.2390.220
Other Working Capital 1.696-4.266-5.347-1.032-0.129-0.134-0.219-0.310.001
Other Non Cash Items 0.2240.3280.1263.19-1.5429.807-0.150.050.03
Operating Cash Flow -11.98-22.686-28.504-8.944-5.385-2.059-0.762-0.317-0.018
Investing Activities:
Investments In Property Plant And Equipment 00-15000-0.100
Acquisitions Net 000000000
Purchases Of Investments 000000000
Sales Maturities Of Investments 000000000
Other Investing Activites 00-15000-0.100
Investing Cash Flow 00-15000-0.100
Financing Activities:
Debt Repayment -5014.951000000
Common Stock Issued 0.7750.69980.25324.90712.2090.92.0560.10.03
Common Stock Repurchased 000-1.01200000
Dividends Paid 000000000
Other Financing Activities 00.031.15300000.350.12
Financing Cash Flow -4.2250.72996.35723.89512.2090.92.0560.450.03
Other Information:
Effect Of Forex Changes On Cash -0.1-0.7-0.010.019-0.015-0.0260.035-0.0030
Net Change In Cash -16.305-22.65752.84314.9716.809-1.1851.2290.130.012
Cash At End Of Period 35.84852.15374.8121.9676.9960.1861.3710.1420.012